Siemens, Draws

Siemens Draws Divergent Analyst Calls as Healthineers Spin-Off and Lauterbach Deal Take Shape

Published on 11/16/2026 at 14:31 | Editorial boerse-global.de
Siemens stock extended its decline after record Q4 orders of €34.8B and 11% revenue growth, as Vertical Research cut to Hold and Evercore raised its target.
Siemens, Draws, Divergent, Analyst, Calls, Healthineers, Spin-Off, Lauterbach, Deal, Take Illustration mit AI erstellt.

Siemens shares fell 2.9% on Monday, extending a retreat that began on Friday following the release of the industrial group's quarterly results. The decline comes even as Evercore ISI lifted its price target on the stock from EUR 315 to EUR 320, keeping its "In Line" rating unchanged.

Media reports attributed Friday's losses to profit-taking after the figures published the previous day — an interpretation tied to Friday's trading session rather than Monday's move. Thursday's numbers had initially driven the stock sharply higher.

At the heart of the results was a record order intake of €34.8 billion for the fourth quarter of fiscal 2026, alongside revenue that climbed 11% to €23.7 billion. Siemens presented the full-year figures and discussed them with analysts and journalists. The company also raised its medium-term revenue growth target corridor from 6–9% to 7–11%, a forward-looking ambition rather than a result already achieved.

Analysts Diverge on the Outlook

The research community has not spoken with one voice. Vertical Research downgraded Siemens from "Buy" to "Hold" on Thursday, according to media reports, with a price target of €300. Evercore ISI moved the other way a day later, nudging its target up to EUR 320 while reaffirming its "In Line" stance — a higher mark that did not come with a change in investment verdict.

Should investors sell immediately? Or is it worth buying Siemens?

Healthineers Hand-Out Slated for 2027

Siemens is planning to transfer its stake in Healthineers to shareholders in fiscal 2027, at a ratio of one Healthineers share for every two Siemens shares. The move would put the medical-technology shares directly into the hands of Siemens investors.

Software Push and Mobility Milestone

Elsewhere on the corporate front, Siemens signed an agreement on 10 November to acquire Lauterbach, a provider of debug and trace solutions for embedded software and SoC architectures. The transaction is subject to regulatory approvals and is expected to close in the first half of 2027.

Siemens Mobility, meanwhile, wrapped up a procurement programme on Friday by handing over the last of 294 Desiro ML Cityjets to Ă–BB. Earlier in the week, on Wednesday, the company unveiled a stainless-steel valve designed for cooling AI data centres.

Siemens at a turning point? This analysis reveals what investors need to know now.

On the Nvidia partnership, CEO Roland Busch told Reuters on Thursday that cooperation would continue regardless of uncertainty over the chipmaker's leadership. His remarks addressed the continuation of the collaboration despite that uncertainty; the Reuters report drew no link between the comments and the share-price decline.

Ad

Siemens Stock: New Analysis - 16 November

Fresh Siemens information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Siemens analysis...

Disclaimer...
en | DE0007236101 | SIEMENS | boerse | 70521020 |